BKAIF Biokey (cayman), Inc.

Fundamentals / CIK 0002108359 / USD

Biokey (cayman), Inc. reported $1.61M in total assets through September 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BKAIF in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for BKAIF.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2025-09-30 2025-06-30
Selling, General & Admin $391K $250K $234K $127K
Total Operating Expenses $391K $250K $234K $127K
Operating Income -$391K -$250K -$234K -$127K
EBITDA -$387K -$246K -$229K -$121K
Interest Expense $44K $42K $41K $36K
Income Before Tax -$398K -$268K -$240K -$145K
Net Income -$398K -$268K -$240K -$145K
Basic EPS -$0.01 -$0.01 -$0.01 -$0.01
Diluted EPS -$0.01 -$0.01 -$0.01 -$0.01
Basic Shares Outstanding 30.0M 30.0M 30.0M 30.0M
Diluted Shares Outstanding 30.0M 30.0M 30.0M 30.0M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for BKAIF.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2025-12-31
Cash & Cash Equivalents $110 $4.6K $2.9K
Cash & Short-Term Investments $110 $4.6K $2.9K
Total Current Assets $27K $59K $62K
Property, Plant & Equipment, Net $66K $71K $81K
Total Non-Current Assets $1.59M $1.66M $1.82M
Total Assets $1.61M $1.72M $1.88M
Deferred Revenue (Current) $13K $13K $13K
Total Current Liabilities $6.31M $5.96M $5.50M
Total Non-Current Liabilities $1.26M $1.32M $1.46M
Total Liabilities $7.56M $7.27M $6.95M
Total Debt (incl. Leases) $1.53M $1.60M $1.73M
Common Stock $3.0K $3.0K $3.0K
Retained Earnings -$5.95M -$5.55M -$5.08M
Total Stockholders' Equity -$5.95M -$5.55M -$5.07M
Total Equity -$5.95M -$5.55M -$5.07M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for BKAIF.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2025-09-30 2025-06-30
Net Income -$398K -$268K -$240K -$145K
Depreciation & Amortization $4.5K $4.6K $5.3K $6.3K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for BKAIF.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2025-09-30 2025-06-30
Current Ratio 0.00x 0.01x -- --
Quick Ratio 0.00x 0.00x -- --
Source: SEC EDGAR CompanyFacts (CIK 0002108359) · from June 30, 2025 Data through September 30, 2026 · synced Nov 21, 2026, 05:18 UTC · Open in terminal